Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,984 public trials 1,830 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)

NCT00464633

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Sanofi-Aventis Investigational Site Number 840008 San Diego, California, United States
  • Sanofi-Aventis Investigational Site Number 840022 San Francisco, California, United States
  • Sanofi-Aventis Investigational Site Number 840010 Chicago, Illinois, United States
  • Sanofi-Aventis Investigational Site Number 840012 Chicago, Illinois, United States
View all 34 locations
View Trial Details
Completed

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00077194

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • Howard University Cancer Center at Howard University Hospital Washington D.C., District of Columbia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States
View Trial Details
Completed

Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma

NCT00002745

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
  • University of Minnesota Cancer Center Minneapolis, Minnesota, United States
  • Washington University Barnard Cancer Center St Louis, Missouri, United States
  • Cooper Cancer Institute Camden, New Jersey, United States
View Trial Details

Related conditions